MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T c
![Cartoon representation of the proposed aggregation model ( A ) CNTO607... | Download Scientific Diagram Cartoon representation of the proposed aggregation model ( A ) CNTO607... | Download Scientific Diagram](https://i1.rgstatic.net/publication/363338808_Simultaneous_affinity_maturation_and_developability_enhancement_using_natural_liability-free_CDRs/links/634067f32752e45ef69dfe61/largepreview.png)
Cartoon representation of the proposed aggregation model ( A ) CNTO607... | Download Scientific Diagram
![A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24767-5/MediaObjects/41467_2021_24767_Fig1_HTML.png)
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications
![Molecular Assessment of Monoclonal Antibody-Based Therapeutics Enabling Lead Selection for Clinical Development | SpringerLink Molecular Assessment of Monoclonal Antibody-Based Therapeutics Enabling Lead Selection for Clinical Development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-1-4939-2543-8_10/MediaObjects/309748_1_En_10_Fig7_HTML.gif)
Molecular Assessment of Monoclonal Antibody-Based Therapeutics Enabling Lead Selection for Clinical Development | SpringerLink
![A single donor is sufficient to produce a highly functional in vitro antibody library | Communications Biology A single donor is sufficient to produce a highly functional in vitro antibody library | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-021-01881-0/MediaObjects/42003_2021_1881_Fig1_HTML.png)
A single donor is sufficient to produce a highly functional in vitro antibody library | Communications Biology
MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T c
![IJMS | Free Full-Text | LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors | HTML IJMS | Free Full-Text | LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors | HTML](https://www.mdpi.com/ijms/ijms-23-09958/article_deploy/html/images/ijms-23-09958-g005.png)
IJMS | Free Full-Text | LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors | HTML
![Frontiers | Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective Frontiers | Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective](https://www.frontiersin.org/files/Articles/547926/fimmu-11-01508-HTML/image_m/fimmu-11-01508-g001.jpg)
Frontiers | Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective
![Notte bianca della biodiversità, ai nastri di partenza l'edizione 2022 dell'evento: alla scoperta della Riserva Mab | isNews - Molise Notte bianca della biodiversità, ai nastri di partenza l'edizione 2022 dell'evento: alla scoperta della Riserva Mab | isNews - Molise](https://www.isnews.it/wp-content/uploads/2022/07/LOCANDINA-NB-2022-696x1005.jpg)